ARHGAP42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.923000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.017200E-01
Normal-vs-Stage2
7.916000E-01
Normal-vs-Stage3
2.639200E-01
Normal-vs-Stage4
5.092800E-01
Stage1-vs-Stage2
5.809600E-01
Stage1-vs-Stage3
3.383800E-01
Stage1-vs-Stage4
3.744400E-01
Stage2-vs-Stage3
1.580750E-01
Stage2-vs-Stage4
5.444400E-01
Stage3-vs-Stage4
9.042000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.384600E-01
Normal-vs-AfricanAmerican
4.593600E-01
Normal-vs-Asian
7.081800E-01
Caucasian-vs-AfricanAmerican
1.009620E-01
Caucasian-vs-Asian
4.323800E-01
AfricanAmerican-vs-Asian
1.095410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.253200E-01
Normal-vs-Female
8.474200E-01
Male-vs-Female
7.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.613800E-01
Normal-vs-Age(41-60Yrs)
5.060600E-01
Normal-vs-Age(61-80Yrs)
9.329400E-01
Normal-vs-Age(81-100Yrs)
7.225200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.905600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.115600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.921800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.563300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.445600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.727400E-01
Normal-vs-Daily Drinker
9.651600E-01
Normal-vs-Weekly Drinker
6.652400E-01
Normal-vs-Occasional Drinker
8.221200E-01
Normal-vs-Social Drinker
7.863000E-01
Non Drinker-vs-Daily Drinker
8.723400E-01
Non Drinker-vs-Weekly Drinker
4.370200E-01
Non Drinker-vs-Occasional Drinker
5.460600E-01
Non Drinker-vs-Social Drinker
5.070000E-01
Daily Drinker-vs-Weekly Drinker
5.172200E-01
Daily Drinker-vs-Occasional Drinker
7.628800E-01
Daily Drinker-vs-Social Drinker
7.397600E-01
Weekly Drinker-vs-Occasional Drinker
2.941400E-01
Weekly Drinker-vs-Social Drinker
2.548600E-01
Occasional Drinker-vs-Social Drinker
9.664200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.597000E-01
Normal-vs-Grade 2
7.496100E-02
Normal-vs-Grade 3
8.781800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.659600E-02
Grade 1-vs-Grade 3
2.402500E-02
Grade 1-vs-Grade 4
3.597000E-01
Grade 2-vs-Grade 3
2.319200E-01
Grade 2-vs-Grade 4
7.496100E-02
Grade 3-vs-Grade 4
8.781800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.050000E-01
Normal-vs-NonDiabetic
9.775200E-01
Diabetic-vs-NonDiabetic
6.477000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.205000E-01
Normal-vs-NoPancreatitis
9.951000E-01
Pancreatitis-vs-NoPancreatitis
3.127000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.055400E-01
Normal-vs-N1
7.686600E-01
N0-vs-N1
1.534650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.129400E-01
Normal-vs-TP53-NonMutant
8.534200E-01
TP53-Mutant-vs-TP53-NonMutant
3.482500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
